ARCHIVES

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

This article is from The Cancer Letter archive.

Vol. 22 No. 39 | October 11, 1996

Download PDF Visit The Full Archive

Related Articles

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

DCE Board Demands Other Agencies Pay For NCI AIDS Support Contract, Okays Two RFA Concepts, One Program Announcement, Contract Recompetitions

May 24, 1985

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Bioassay Program To NIEHS” NCI Denies Rumor

March 31, 1978